Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 13, 2020 Filed Feb 5, 2021 22:37 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
OtherCommon Stock 15 $4.03 $60.45
Disclosure

SEC source: 0001209191-21-008216 · doc5.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,790,422

F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020.

F2 · shares: Filing 1 of 6.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:25 UTC GrantCommon Stock 1,000 $3.56 $3,560.00
Disclosure

SEC source: 0001209191-20-024903 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,268

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:24 UTC GrantCommon Stock 1,000 $3.56 $3,560.00
Disclosure

SEC source: 0001209191-20-024900 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,495

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:22 UTC GrantCommon Stock 5,000 $3.56 $17,800.00
Disclosure

SEC source: 0001209191-20-024892 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,415

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:23 UTC
Jones JamesDirector
GrantCommon Stock 1,000 $3.56 $3,560.00
Disclosure

SEC source: 0001209191-20-024896 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,700

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:20 UTC GrantCommon Stock 1,000 $3.56 $3,560.00
Disclosure

SEC source: 0001209191-20-024889 · doc4.xml · nonDerivative · entry 1

Griggs Jonathan · CIK 0001490828 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,803

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:19 UTC GrantCommon Stock 1,000 $3.56 $3,560.00
Disclosure

SEC source: 0001209191-20-024884 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,692

F1 · shares: Restricted stock award will vest 100% on March 23, 2021.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:18 UTC
Bonner MichaelChief Financial Officer
GrantCommon Stock 2,500 $3.56 $8,900.00
Disclosure

SEC source: 0001209191-20-024880 · doc4.xml · nonDerivative · entry 2

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,287

F2 · shares: Restricted stock award will vest 100% on March 23, 2024.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:17 UTC
Herman James LVP and Chief Compliance Office
GrantCommon Stock 4,000 $3.56 $14,240.00
Disclosure

SEC source: 0001209191-20-024878 · doc4.xml · nonDerivative · entry 2

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,561

F2 · shares: Restricted stock award will vest 100% on March 23, 2024.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:16 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
GrantCommon Stock 5,000 $3.56 $17,800.00
Disclosure

SEC source: 0001209191-20-024876 · doc4.xml · nonDerivative · entry 2

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,759

F2 · shares: Restricted stock award will vest 100% on March 23, 2024.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:14 UTC
Pavliv LeoSVP and Chief Development Off.
GrantCommon Stock 25,000 $3.56 $89,000.00
Disclosure

SEC source: 0001209191-20-024873 · doc4.xml · nonDerivative · entry 2

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,988

F2 · shares: Restricted stock award will vest 100% on March 23, 2024.

Read SEC document
March 23, 2020 Filed Apr 17, 2020 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GrantCommon Stock 100,000 $3.56 $356,000.00
Disclosure

SEC source: 0001209191-20-024872 · doc4.xml · nonDerivative · entry 2

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,790,407

F2 · shares: Restricted stock award will vest 100% on March 23, 2024.

Read SEC document
March 18, 2020 Filed Apr 17, 2020 21:18 UTC
Bonner MichaelChief Financial Officer
Tax withholdingCommon Stock 2,134 $3.53 $7,533.02
Disclosure

SEC source: 0001209191-20-024880 · doc4.xml · nonDerivative · entry 1

Bonner Michael · CIK 0001666790 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,787

F1 · shares: This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 18, 2020 Filed Apr 17, 2020 21:17 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 1,173 $3.53 $4,140.69
Disclosure

SEC source: 0001209191-20-024878 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,561

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 18, 2020 Filed Apr 17, 2020 21:16 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
Tax withholdingCommon Stock 1,186 $3.53 $4,186.58
Disclosure

SEC source: 0001209191-20-024876 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,759

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 18, 2020 Filed Apr 17, 2020 21:14 UTC
Pavliv LeoSVP and Chief Development Off.
Tax withholdingCommon Stock 9,637 $3.53 $34,018.61
Disclosure

SEC source: 0001209191-20-024873 · doc4.xml · nonDerivative · entry 1

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,988

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
March 18, 2020 Filed Apr 17, 2020 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
Tax withholdingCommon Stock 37,209 $3.53 $131,347.77
Disclosure

SEC source: 0001209191-20-024872 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,690,407

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 22:16 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
GiftCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-061984 · doc4.xml · nonDerivative · entry 1

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,727,616

F1 · shares: Transaction is a charitable donation.

Read SEC document
December 04, 2019 Filed Dec 6, 2019 22:15 UTC SaleCommon Stock 1,000 $4.79 $4,790.00
Disclosure

SEC source: 0001209191-19-059516 · doc4.xml · nonDerivative · entry 1

Bernard Gordon R · CIK 0001470015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. This plan was established due to the policy change at Vanderbilt Medical Center requiring that senior executives divest holdings in biopharmaceutical companies.

Read SEC document
November 26, 2019 Filed Nov 29, 2019 22:26 UTC
Herman James LVP and Chief Compliance Office
Tax withholdingCommon Stock 2,149 $4.93 $10,594.57
Disclosure

SEC source: 0001209191-19-058442 · doc4.xml · nonDerivative · entry 1

Herman James L · CIK 0001572342 · VP and Chief Compliance Office

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,734

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
November 26, 2019 Filed Nov 29, 2019 22:24 UTC
Pavliv LeoSVP and Chief Development Off.
Tax withholdingCommon Stock 3,710 $4.93 $18,290.30
Disclosure

SEC source: 0001209191-19-058440 · doc4.xml · nonDerivative · entry 1

Pavliv Leo · CIK 0001408593 · SVP and Chief Development Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,051

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
November 26, 2019 Filed Nov 29, 2019 22:25 UTC
Cearnal Martin EDirector · Sr VP/Chief Commercial Officer
Tax withholdingCommon Stock 472 $4.93 $2,326.96
Disclosure

SEC source: 0001209191-19-058441 · doc4.xml · nonDerivative · entry 1

Cearnal Martin E · CIK 0001408500 · Director · Sr VP/Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,945

F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.

Read SEC document
October 20, 2019 Filed Oct 25, 2019 21:15 UTC PurchaseCommon Stock 14 $5.46 $76.44
Disclosure

SEC source: 0001209191-19-054168 · doc4.xml · nonDerivative · entry 26

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,268

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 19, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 38 $5.51 $209.38
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 21

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,495

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 18, 2019 Filed Oct 25, 2019 21:15 UTC PurchaseCommon Stock 50 $5.48 $274.00
Disclosure

SEC source: 0001209191-19-054168 · doc4.xml · nonDerivative · entry 25

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,254

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 18, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.45 $354.25
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 20

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,457

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 18, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 34 $5.45 $185.30
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 20

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,692

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 18, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 34 $5.45 $185.30
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 20

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,616

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 17, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.52 $358.80
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 19

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,392

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 17, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.52 $331.20
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 19

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,658

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 17, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.52 $331.20
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 19

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,582

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 16, 2019 Filed Oct 25, 2019 21:15 UTC PurchaseCommon Stock 50 $5.54 $277.00
Disclosure

SEC source: 0001209191-19-054168 · doc4.xml · nonDerivative · entry 24

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,204

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 16, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.56 $361.40
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 18

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,327

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 16, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.56 $333.60
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 18

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,598

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 16, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.56 $333.60
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 18

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,522

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 15, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.63 $365.95
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 17

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,262

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 15, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.63 $337.80
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 17

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,538

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 15, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.63 $337.80
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 17

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,462

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 14, 2019 Filed Oct 25, 2019 21:15 UTC PurchaseCommon Stock 50 $5.65 $282.50
Disclosure

SEC source: 0001209191-19-054168 · doc4.xml · nonDerivative · entry 23

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,154

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 14, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.67 $368.55
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 16

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,197

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 14, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.67 $340.20
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 16

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,478

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 14, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.67 $340.20
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 16

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,402

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 11, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.71 $371.15
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 15

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,132

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 11, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.71 $342.60
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 15

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,418

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 11, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.71 $342.60
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 15

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,342

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 10, 2019 Filed Oct 25, 2019 21:15 UTC PurchaseCommon Stock 50 $5.78 $289.00
Disclosure

SEC source: 0001209191-19-054168 · doc4.xml · nonDerivative · entry 22

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,104

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 10, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.86 $380.90
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 14

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,067

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 10, 2019 Filed Oct 25, 2019 21:12 UTC PurchaseCommon Stock 60 $5.86 $351.60
Disclosure

SEC source: 0001209191-19-054164 · doc4.xml · nonDerivative · entry 14

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,358

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 10, 2019 Filed Oct 25, 2019 21:13 UTC
KAZIMI A JDirector · Chairman and CEO · 10% owner
PurchaseCommon Stock 60 $5.86 $351.60
Disclosure

SEC source: 0001209191-19-054166 · doc4.xml · nonDerivative · entry 14

KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,767,282

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document
October 09, 2019 Filed Oct 25, 2019 21:14 UTC PurchaseCommon Stock 65 $5.78 $375.70
Disclosure

SEC source: 0001209191-19-054167 · doc4.xml · nonDerivative · entry 13

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,002

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.